FDA drug safety: Singulair case shows systemic surveillance flaws

AdobeAfteradrugentersthemarket,it’suptoFoodandDrugAdministrationregulatorstoensureitscontinuedsafety PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year




Wikipedia

author：hotspot    Page View：5726
D.C. Insight IMAGE
Alex Hogan/STAT

You’re reading the web edition of D.C. Diagnosis. Sign up here to receive this newsletter in your inbox on Tuesdays and Thursdays.

About last night…

advertisement

House leadership last night canceled a scheduled vote on a health care package that included transparency requirements for hospitals and insurers, reforms to some PBM practices, and a small site-neutral payment policy for administering drugs, Rachel writes.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In
Previous article： Juul spent big to court Black leaders to promote its e
Next article： Walensky prepares to leave CDC — and Congress — behind